Santhera Pharmaceuticals Holdings Ltd. revenue for the last year amounted to 950.19 k USD, the most of which — 122.83 M USD — came from its highest performing source at the moment, Specialty Niche Products, the year earlier bringing 8.08 M USD. The greatest contribution to the revenue figure was made by North America — last year it brought Santhera Pharmaceuticals Holdings Ltd. 116.51 M USD.